1. OC-0264 CDK4/CDK6 inhibition radiosensitises HPV-neg HNSCC through inhibition of homologous recombination. (April 2019) Authors: Gottgens, E.; Leszczynska, K.; Bussink, J.; Hammond, E.; Span, P. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0282 Inhibition of oxidative phosphorylation alters the tumor microenvironment in syngeneic mouse models. (August 2021) Authors: Boreel, D.; Span, P.; Kip, A.; Peters, H.; van den Bijgaart, R.; Heskamp, S.; Adema, G.; Bussink, J. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-0399 Co-occurrence of APOBEC3B and Homologous Recombination Deficiency is Rare in Breast Cancer. (August 2021) Authors: Span, P.; Jarvis, M.; Martens, J.; Harris, R.; Roelofs, P. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC-0429 Tamoxifen induces metabolic adaptations leading to radioresistance in breast cancer. (May 2022) Authors: Naumann, F.; Adema, G.; Sweep, F.; Bussink, J.; Span, P. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC-0447: ATP Citrate Lyase is associated with radiosensitivity in head and neck squamous cell carcinoma. (November 2020) Authors: Göttgens, E.; Van den Heuvel, C.; De Jong, M.; Kaanders, J.; Leenders, W.; Ansems, M.; Bussink, J.; Span, P. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OC-0482: Interferon stimulated genes: a common pathway in tamoxifen- and radioresistance in breast cancer. (May 2017) Authors: Post, A.; Smid, M.; Nagelkerke, A.; Martens, J.; Bussink, J.; Sweep, C.; Span, P. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OC-0593 SPECT Imaging of CAIX and monitoring of hypoxia after OXPHOS inhibition in murine tumor models. (May 2022) Authors: Boreel, D.; Span, P.; Peters, H.; Kip, A.; Boswinkel, M.; Adema, G.; Heskamp, S.; Bussink, J. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S517 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PH-0441 DNA- and mitochondrial damage may be involved in tamoxifen-induced radioresistance. (August 2021) Authors: Naumann, F.; Adema, G.; Sweep, F.; Bussink, J.; Span, P. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PO-0771: Hypofractionated high-dose IMRT: effective and less toxic than 2D-RT in incurable head and neck cancer. (April 2015) Authors: Van Beek, K.M.; Kaanders, J.H.A.M.; Janssens, G.O.R.J.; Takes, R.P.; Span, P.; Verhoef, C.G. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: S383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PO-1077 The heterogeneous metabolic and mutational landscape of non-small cell lung carcinomas. (April 2019) Authors: Van Zon-Meijer, T.; Peeters, W.; Looijen-Salamon, M.; Biemans, R.; Dubois, L.; Span, P.; Bussink, J. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S598 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗